Loading...
Although few women base their contraceptive decisions solely on dollars and cents, cost and insurance coverage often are factors that they consider. In a study supported by a manufacturer of oral contraceptives and the levonorgestrel-containing intrauterine device Mirena, researchers used a mathematical model to evaluate the relative cost-effectiveness of the major contraceptive options (vasectomy and tubal ligation; oral, transdermal, and vaginally delivered hormones; levonorgestrel-containing and copper intrauterine devices; male and female condoms; injections and implants; diaphragm; sponge; spermicides; withdrawal; and fertility-awareness–based approaches). The model was based on costs and savings to healthcare payers during a 5-year pe…